An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)
- Status
- COMPLETED
- Phase
- N/A
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
- Status
- COMPLETED
- Phase
- PHASE3
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE3
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab-PET Imaging
- Status
- COMPLETED
- Phase
- NA
Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
- Status
- UNKNOWN
- Phase
- N/A
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus
- Status
- COMPLETED
- Phase
- NA
Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib
- Status
- COMPLETED
- Phase
- PHASE2
RT Plus EGFR-TKI for Wild-type NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Detection Cell Free DNA in Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Paclitaxel Detection in NSCLC Treated With TC Regimen
- Status
- TERMINATED
- Phase
- PHASE2
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2